MD and CEO resigns, promoter family member named new Managing Director
DSFCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.9 pts more than Nifty Microcap 250 and 1.6 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board approved Q1 FY26 results: standalone revenue Rs 90.78 crore (down from Rs 98.62 crore year-on-year). Net profit Rs 2.42 crore versus Rs 4.13 crore. MD and CEO Mr. Akshay Dhar resigned to lead new projects. Mr. Rudra Shriram, Chairman's son, appointed new MD for 5 years. Mr. Rakesh Malhotra named Independent Director.
Promoter family member becoming new MD raises governance focus. Revenue declined about 8 percent and profit fell about 41 percent year-on-year.